| Dr Kamel M Sadek, MD | |
|
10815 W Mcdowell Rd Ste 305, Avondale, AZ 85392-5016 | |
| (623) 936-3312 | |
| (623) 936-4248 |
| Full Name | Dr Kamel M Sadek |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 10815 W Mcdowell Rd Ste 305, Avondale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144384603 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 28344 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group Arizona Llc | 3173872835 | 198 |
News Archive
A CDC food safety alert regarding a multistate outbreak of Salmonella Enteritidis infections has been posted: https://www.cdc.gov/salmonella/enteritidis-06-21/index.html
Pfizer Inc. today announced randomized Phase 2 data that showed PD-0332991 (PD-991) in combination with letrozole significantly extended progression free survival (PFS) compared with letrozole alone in post-menopausal patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer.
A new study from engineering researchers at Rensselaer Polytechnic Institute shows, for the first time, how the little-understood protein osteocalcin plays a significant role in the strength of our bones. The findings could lead to new strategies and therapeutics for fighting osteoporosis and lowering the risk of bone fracture.
Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).
Initial results from an international, investigator-initiated, open label phase III trial were presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism. Data indicate that haematopoietic stem cell transplantation (HSCT) results in better long term survival than conventional treatment for patients with poor prognosis early diffuse cutaneous systemic sclerosis.
› Verified 4 days ago
| Entity Name | Summit Medical Group Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053810622 PECOS PAC ID: 3173872835 Enrollment ID: O20180814003015 |
News Archive
A CDC food safety alert regarding a multistate outbreak of Salmonella Enteritidis infections has been posted: https://www.cdc.gov/salmonella/enteritidis-06-21/index.html
Pfizer Inc. today announced randomized Phase 2 data that showed PD-0332991 (PD-991) in combination with letrozole significantly extended progression free survival (PFS) compared with letrozole alone in post-menopausal patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer.
A new study from engineering researchers at Rensselaer Polytechnic Institute shows, for the first time, how the little-understood protein osteocalcin plays a significant role in the strength of our bones. The findings could lead to new strategies and therapeutics for fighting osteoporosis and lowering the risk of bone fracture.
Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).
Initial results from an international, investigator-initiated, open label phase III trial were presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism. Data indicate that haematopoietic stem cell transplantation (HSCT) results in better long term survival than conventional treatment for patients with poor prognosis early diffuse cutaneous systemic sclerosis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kamel M Sadek, MD 3815 E Bell Rd Ste 2200, Phoenix, AZ 85032-2139 Ph: (602) 633-3848 | Dr Kamel M Sadek, MD 10815 W Mcdowell Rd Ste 305, Avondale, AZ 85392-5016 Ph: (623) 936-3312 |
News Archive
A CDC food safety alert regarding a multistate outbreak of Salmonella Enteritidis infections has been posted: https://www.cdc.gov/salmonella/enteritidis-06-21/index.html
Pfizer Inc. today announced randomized Phase 2 data that showed PD-0332991 (PD-991) in combination with letrozole significantly extended progression free survival (PFS) compared with letrozole alone in post-menopausal patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer.
A new study from engineering researchers at Rensselaer Polytechnic Institute shows, for the first time, how the little-understood protein osteocalcin plays a significant role in the strength of our bones. The findings could lead to new strategies and therapeutics for fighting osteoporosis and lowering the risk of bone fracture.
Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).
Initial results from an international, investigator-initiated, open label phase III trial were presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism. Data indicate that haematopoietic stem cell transplantation (HSCT) results in better long term survival than conventional treatment for patients with poor prognosis early diffuse cutaneous systemic sclerosis.
› Verified 4 days ago
Dr. Steven Rush Sumpter, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10815 W Mcdowell Rd, 201, Avondale, AZ 85392 Phone: 602-433-0155 Fax: 623-433-0185 | |
Dr. Krista Deann Pellicore, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 235 W Western Ave, Avondale, AZ 85323 Phone: 602-230-7373 Fax: 602-230-3086 | |
Mrs. Meaghan Patricia Payne, FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10705 W Indian School Rd, Avondale, AZ 85392 Phone: 602-743-5458 | |
Dr. Mark S Bessette, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3125 N Dysart Rd, Avondale, AZ 85392 Phone: 623-882-9161 Fax: 623-925-0745 | |
Dr. Goshtasb Javdan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 E Van Buren St, Avondale, AZ 85323 Phone: 623-344-6800 Fax: 623-344-6801 | |
Dr. Phat Dai Hoang, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13065 W Mcdowell Rd, Suite A105, Avondale, AZ 85392 Phone: 623-536-6788 Fax: 623-536-9288 |